[HTML][HTML] Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

J Bousquet, HJ Schünemann, B Sousa-Pinto… - The Journal of Allergy …, 2024 - Elsevier
The traditional healthcare model is focused on diseases (medicine and natural science) and
does not acknowledge patients' resources and abilities to be experts in their own lives …

Rhinitis disease burden and the impact of social determinants of health

SK Wise, Y Hamzavi-Abedi, PA Hannikainen… - The Journal of Allergy …, 2024 - Elsevier
Social determinants of health (SDHs) have a substantial impact on patient care and
outcomes globally, both in low-to middle-income countries and in high-income countries. In …

Postnasal drip and chronic cough in patients with chronic rhinitis treated with temperature‐controlled radiofrequency neurolysis

D Gorelik, JG Ahmad, SE Razmi… - … Forum of Allergy & …, 2024 - Wiley Online Library
Objective To evaluate the contribution of postnasal drip (PND) and chronic cough (CC) to
symptoms of patients with chronic rhinitis treated with temperature‐controlled …

ROS responsive hydrogel for inhibition of MUC5AC against allergic rhinitis: A new delivery strategy for Ipratropium Bromide

Q Zhao, M Gu, M Ni, J Li, T Wu, S Zhu, Y Zhou… - Colloids and Surfaces B …, 2024 - Elsevier
Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal mucosa mediated by
immunoglobulin E (IgE) after exposure to allergens. The bothersome symptoms of AR, such …

Using ipratropium bromide nasal spray response as a screening tool in the diagnostic workup of cerebrospinal fluid rhinorrhea

P Nulty, W Mason, H Mackie, EL Peterson… - The …, 2024 - Wiley Online Library
Objectives Unilateral clear thin rhinorrhea (UCTR) can be concerning for a nasal
cerebrospinal fluid (CSF) leak. Beta‐2 transferrin electrophoresis has been the gold …

A Randomized Comparison of Bencycloquidium Bromide, Mometasone Furoate, and a Combination for Persistent Allergic Rhinitis

X Li, X Wang, Q Yang, J Chen, H Tian, M Lu… - The Journal of Allergy …, 2024 - Elsevier
Background Moderate to severe persistent allergic rhinitis (AR) poses a substantial
socioeconomic burden. Objectives We aimed to establish the superiority of bencycloquidium …

Expert consensus on nasal anticholinergics in the treatment of allergic rhinitis

H Hong, Z Liao, Q Yang, Y Sun, F Chen, W Liu… - IJS Global …, 2025 - journals.lww.com
Background: Allergic rhinitis (AR) is a common hyperreactive nasal disease in
otolaryngology, mainly manifested as rhinorrhea, nasal obstruction, nasal itching, and …

Nasal sprays: commonly used medications that are often misunderstood

SP Williams, AC Swift - British Journal of Hospital Medicine, 2023 - magonlinelibrary.com
Sinonasal inflammatory disease is very common and all clinicians who care for these
patients should understand the topical treatment options available. This article reviews the …

Grundlagen der Allergologie für die HNO-Sprechstunde

J Kornmann, B Kramer, D Haeussler - Laryngo-Rhino-Otologie, 2024 - thieme-connect.com
Allergies play a pivotal role in the daily practice of ENT specialists. Allergic symptoms
induced by inhalant allergens are widespread in the population and can manifest through a …

Effect of topical anticholinergic medication on clinical manifestations control among patients with vasomotor rhinitis versus allergic rhinitis: as comparative clinical trials

AM Askoura, SM Sabry, SA Fawaz, MI Salman… - The Egyptian Journal of …, 2023 - Springer
Background The use of a topical anticholinergic medication, ipratropium bromide, and its
ability to inhibit methacholine and rhinitis-induced hypersecretion is emphasized …